CCSS Supports the Dietary Supplement Listing Act of 2022

CCSS applauds Sen. Durbin (D-IL) and Sen. Braun (R-IN) for their efforts to protect public health through introduction of the bipartisan S. 4090 Dietary Supplement Listing Act of 2022. If enacted, this would require dietary supplement manufacturers to list their products with the Food Drug Administration (FDA).

Click here to view PDF